Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Clinical trial NCT00121095 · UNKNOWN
Trial details
- NCT number
- NCT00121095
- Sponsor
- Cytogen Corporation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.